TD PRIVATE CLIENT WEALTH LLC

Position in ROIV — Roivant Sciences Ltd.

CIK 1551017 NEW YORK, NY

Position in ROIV

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$24,702

+$1,767 QoQ

Shares Held

698

-15.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#394

of 494 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

TD PRIVATE CLIENT WEALTH LLC holds $2,696,000 across 45 Biotechnology names. ROIV ranks #9 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,440	$731,270
2	JAZZ	Jazz Pharmaceuticals plc	2,863	$689,897
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,361	$676,049
4	GMAB	Genmab A/S	4,376	$120,208
5	REGN	Regeneron Pharmaceuticals, Inc.	150	$93,531
6	MRNA	Moderna, Inc.	1,305	$91,389
7	INSM	INSMED Inc	517	$55,122
8	ARGX	Argenx SE	28	$25,977

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$24,702	698	-15.7%	Shares	Defined	2026-08-04
2026-03-31	$22,935	828	+0.1%	Shares	Defined	2026-04-27
2025-12-31	$17,945	827	+0.9%	Shares	Defined	2026-02-05
2025-09-30	$12,406	820	0.0%	Shares	Defined	2025-10-27
2025-06-30	$9,241	820	+80.6%	Shares	Defined	2025-07-15
2025-03-31	$4,580	454	0.0%	Shares	Defined	2025-04-29
2024-09-30	$5,239	454	0.0%	Shares	Defined	2024-11-18
2024-06-30	$4,798	454	+20.1%	Shares	Defined	2024-08-14
2024-03-31	$3,984	378	-16.0%	Shares	Defined	2024-08-16
2023-12-31	$5,053	450	-29.8%	Shares	Defined	2024-08-16
2023-09-30	$7,486	641	-64.6%	Shares	Defined	2024-08-16
2023-06-30	$18,234	1,809	—	Shares	Defined	2024-08-16
No filing history on record for this holder in this stock.